A study analysing clinical and radiological features of COVID-19 pneumonitis and factors predicting fibrotic evolution
Latest Information Update: 10 Nov 2020
At a glance
- Drugs Darunavir/ritonavir (Primary) ; Hydroxychloroquine (Primary) ; Lopinavir/ritonavir (Primary)
- Indications COVID-19 pneumonia; Fibrosis
- Focus Therapeutic Use
- 10 Nov 2020 New trial record
- 01 Oct 2020 Results published in the International Journal of Infectious Diseases